SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity

Biomedical and Environmental Sciences

Volumn 18, Issue 6, 2005, Pages 363-374

  Liang, Mi Fang ^a,c   Du, Run Lei ^a   Liu, Jing Zhi ^a   Li, Chuan ^a   Zhang, Quan Fu ^a   Han, Lu Lu ^a   Yu, Jian Shi ^a   Duan, Shu Min ^a   Wang, Xiao Fang ^b   Wu, Kong Xing ^a   Xiong, Zhao Hui ^b   Jin, Qi ^b   Li, De Xin ^a,b  

^a Institute for Viral Disease Control and Prevention   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c China CDC   (China)

Author keywords

Human antibody; Phage display; SARS CoV

Indexed keywords

ESCHERICHIA COLI; SARS CORONAVIRUS;

EID: 32444437275     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Peiris, J. S. M., Lai, S. T. L., Poon, L. M., Guan, Y. L., Yam, Y. C., Lim, W., Nicholls, J., Yee, W. K. S., Yan, W. W., Cheung, M. T., Cheng, V. C. C., Chan, K. H., Tsang, D. N., Yung, R. W., Ng, T. K., Yuen, K. Y., and members of the SARS study group. (2003). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet Published online 8 April, 2003 (http://image.thelancet.com/extras/03art3477web.pdf).
2. Drosten, C., Günther, S., Preiser, W., Werf, S., Brodt, H.R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A. M., Cinatl, J., Eickmann, Markus., Escriou, N., Grywna, K., Kramme, Stefanie., Müller, S., Rickerts, Volker., Stürmer, M., and Doerr, H. W. (2003). Identification of a novel conronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. Published online 10, April 2003 (10.1056/NEJMoa030781).
3. Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, Robert A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K. Barber, S. A., Chan, S. Y., and Roper, R. L. (2003). The Genome Sequence of the SARS-Associated Coronavirus. Sciencexpres./ www.sciencexpress.org/1 May, 2003/Page 4/10.1126/science.1085953.
4. Barbas, C. F. 3rd and Burton, D. R. (1996). Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol 14(7), 230-234.
5. Sawyer, L. A. (2000). Antibodies for the prevention and treatment of viral diseases. Antiviral Research 47, 57-77.
6. Peiris, J. S. M., Chu, C. M., Cheng, V. C. C., Chan, K. S., Hung, I. F. N., Poon, L. L., Law, M. K. I., Tang, B. S. F., Hon, T. Y. W., Chan, C. S., Chan, K. H., Ng, J. S. C., Zheng, B. J., Ng, W. L., Lai, R. W. M., Guan, Y., and K. Y. Yuen. (2003). Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767-1772.
7. Ng, M. L, Tan, S. H., See, E. E, Ooi, E. E., and Ling, A. E. (2003). Early events of SARS Coronavirus infection in Vero cells. Journal of Medical Virology 71, 323-331.
8. Duan, S. M., Zhao, X. S., Weng, R. F., LI, D. X., Hong, T., Bi, S. L., Wang, J. W., Yu, J. S., Hu, K. X., Huang, J. J., Zhang, S. X., Xu, Hong., Xu, W. B., Guan, Y. J., Da, S. L., Dong, X. P., and Ruan, Li. (2004). Isolation and preliminary Identification of SARS Coronavirus from various speciments of SARS patients. Chinese J. Virology 19(3), 193-198.
9. Barbas, C. FIII., Kang, A. S., and larner, R. A. (1991). Assembly of combinatorial antibody libraries on phage surface: the gene II site. Proc. Natl. Acad. Sci. USA. 88(18), 7978-7982.
10. Liang, M. F., Stefan, D., Li, D. X., Queitsch, I., Li, W., and Bautz, E. F. K. (2001). Baculovirusexpression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. Journal of Immunological Methods 247, 119-130.
11. Gallagher, T. M. and Buchmeier, M. J. (2001). Coronavirus Spike Proteins in Viral Entry and Pathogenesis. Virology 279, 371-374.
12. Li, Wi., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne M. A., Somasundaran M., Sullivan, J. L., Luzuriaga, K. A., Greenough, T. C., Choe, H., and Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(27), 450-453.
13. Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., St. Clair, T. A., Olurinde, M., Choe, H., Anderson, L. J., Bellin, W. J., Farzan, I., Marasco, W. A. (2004). Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. PNAS 101(8), 2536-2541.
14. Fields, B. N., Knipe, D. M., Howley, P. M., and Griffin, D. E. (2001). Fields Virology (Lippincott Williams & Wilkins, Philadelphia, ed. 4).
15. Bosch, B. J., Van der, Z. R., Haan, C. A., and Rottier P. J. (2003). The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J of Virology. 77(16), 8801-8811.
16. Jackwood, M. W., Hilt, D. A., Callison, S. A., Lee, C. W., Plaza, H., and Wade E. (2001). Spike glycoprotein cleavage recognition site analysis of infectious bronchitis virus. Avian Disease. 45(2), 366-372.
17. Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Penaranda, S., Bankamp, B., Mane, K., Chen, M. H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J. L., Chen, Q. Wang, D., Erdman, D. D., Peret, T. C., Burns, C., Ksiazek, T. G., Rollin, P. E., Sanchez, A., Liffick, S., Holloway, B., Limor, J. McCaustland, K., Olsen-Rasmussen, M., Fouchie, R., Gunther, S., Osterhaus, A. D., Drosten, C., Pallansch, M. A., Anderson, L. J., and Bellini, W. J. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 30(300), 1377-1399.